Cem mirili

Doç Dr, İç hastalıkları ve Tıbbi Onkoloji Uzmanı, BeşiktAŞK, Özel Adana Ortadoğu Hastanesi

[Cem mirili @MiriliCem]

@DrYukselUrun @OncoAlert @OpenMedicineHQ Surgery😂 Keep this away from the urologists😂

[Cem mirili @MiriliCem]

@hatice_bolek @myESMO @AUTF_DEKANLIK @DrYukselUrun @yekeduz_emre Excellent results. Congratulations 👏👏

[Cem mirili @MiriliCem]

@yekeduz_emre @OncoAlert @DrYukselUrun @nataliagandur @MikeSerzanMD I read it, excellent review. I want to learn your opinion about 75 + patients. Do you think there is any difference in efficacy among ARPI agents in patients over 75 years of age?

[Cem mirili @MiriliCem]

@to_be_elizabeth @_SEOM @GEICAM @_SOLTI Thank you for sharing. What do you think about neoadjuvant hormonotherapy ? What is your target population? Do you routinely use it? @Larvol #breastcancer

[Cem mirili @MiriliCem]

@dr_yakupergun I agree with you 👍🏻

[Cem mirili @MiriliCem]

@GIMedOnc Thank you for good summary. I agree with you in Pdl postivie subroup. But ı want to learn how many patients in pdl1 negative group. Efficacy of durva in pdl1 nagative is as certain as like pdl1 positive?

[Cem mirili @MiriliCem]

@ozdogan_md Hocam çok güzel özetlemişssin hepsini, emeğinize sağlık

[Cem mirili @MiriliCem]

@ademmaman Tebriklerm Adem hocam, başarılarının devamını dilerim

[Cem mirili @MiriliCem]

@yekeduz_emre @DrYukselUrun @ErulEnes @BbaharK Thank you for response👍🏻

[Cem mirili @MiriliCem]

@yekeduz_emre @OncJournal @OUPAcademic @susanebates @OncoAlert @DrChoueiri Süpersin Emre hocam, gurur duyduk, başarılarının devamını diliyorum

[Cem mirili @MiriliCem]

@SuyogCancer I want to join this group. Can you send me dm

[Cem mirili @MiriliCem]

@NSerdarTurhal Tebrikler hocam

[Cem mirili @MiriliCem]

@Dr_RShatsky Most of the time our patients cannot afford the oncotype fee. In such cases, would ki67 be important to you? <10, 10-20, >20?

[OncoAlert @OncoAlert]

The OncoAlert🚨Weekly Round Up
Covering the TOP of the week April 4-10, 2025

REGISTER at https://t.co/QFM2SYXqbg OR https://t.co/hwvqbilbLO

Discussing:
✅Prognostic implications of risk definitions from the monarchE and NATALEE trial

https://t.co/TsDMrtYPrD

✅Evaluating impact of histological 🆚 nuclear grading on CPS + EG Score for HR + /HER2-early #breastcancer

https://t.co/V2Mdp6Znhx

✅FDA🇺🇸 approves nivolumab w/ipilimumab🧪 for unresectable/metastatic MSI-H or dMMR #ColorectalCancer

https://t.co/0xA68PVF37

✅Circulating tumor DNA🧬analysis guiding adjuvant therapy in stage II #ColonCancer : DYNAMIC trial

https://t.co/9bDUXhXyqx

✅Assessment of a Polygenic Risk Score in Screening for #ProstateCancer (BARCODE1)

https://t.co/4RjB9nk1Gc

✅Neoadjuvant Aumolertinib for unresectable stage III EGFR-mutant non-small cell🫁 #LungCancer #NSCLC

https://t.co/6bDed633mt

✅Circulating tumor DNA🧬 Clearance as a Predictive Biomarker of Pathologic Complete Response in Patients with Solid Tumors Treated with Neoadjuvant Immune-Checkpoint Inhibitors:

https://t.co/RzCkK4gzh0

@BlondeauxEva @matteolambe @DrHBurstein @DrChoueiri @ArndtVogel @SuyogCancer @DraMartinezLago @GIMedOnc @MiriliCem @giammi107 @5_utr @UGrewalMD @RenoHemonc @EricTopol @AlexTISYoung @SashaGusevPosts @hsu_steve @DrJNaidoo @OscarTahuahua @DipeshUpretyMD @aminfield @ESaldanhaMD @VivekSubbiah @ValenzaCarmine @peters_solange @AnnPartridgeMD @darioT_ @quimmateo @drenriquegrande @PietroDePlacido @drenriquegrande

#OncoAlertAF
@nataliagandur @acampsmalea @BiagioRicciutMD
@yekeduz_emre @HHorinouchi @FadiHaddad_MD
@Abdallah81MD @FernandoOnco
@ElisaAgostinett @to_be_elizabeth @bavilima @realbowtiedoc @Erman_Akkus @Lucarecco @GaiaGriguolo @JankovicK

[Cem mirili @MiriliCem]

@Erman_Akkus @OncoAlert @myESMO @ASCO @EORTC I want to learn your thoughts.
Which tki? There are lots of tki. I look at the paper and they mention sunitinib imatinib. What dou you think about it?

[Cem mirili @MiriliCem]

@GIMedOnc @dr_yakupergun @NatureMedicine I start offering ct dna but Patient selection is important in this issue . İf patient doesnt want chemo, it is very useful to use this : older, low performance status. But another problem is which test is best? Cost of test. I m talking all of this with my patients. Dou you offer

[Cem mirili @MiriliCem]

@dr_yakupergun @NatureMedicine I think like you too. Thank you doc Yakup